Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Decitabine/venetoclax

Enterobacter cloacae bacteremias infection and thrombocytopenia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zheng W, et al. Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients. Blood 142 (Suppl. 1): 5934, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-191155 [abstract] Zheng W, et al. Ultra-Low-Dose of Decitabine with Venetoclax As Induction and Consolidation Therapy for Elderly or Frail Newly Diagnosed Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Patients. Blood 142 (Suppl. 1): 5934, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-191155 [abstract]
Metadaten
Titel
Decitabine/venetoclax
Enterobacter cloacae bacteremias infection and thrombocytopenia
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55536-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Methotrexate

Case report

Prednisolone

Case report

Pembrolizumab